Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece

Clinical trial NCT04084613 · UNKNOWN

Trial details

NCT number: NCT04084613
Sponsor: Attikon Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Severe Eosinophilic Asthma

Start date: 2017-01-01
Primary completion: 2020-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.